BioGend Therapeutics Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was TWD 1.088 million compared to TWD 373,000 a year ago. Operating loss was TWD 44.022 million compared to TWD 33.766 million a year ago. Net loss was TWD 46.834 million compared to TWD 37.184 million a year ago. Basic loss per share was TWD 0.47 compared to TWD 0.45 a year ago.